FDA approves Pfizer’s COVID-19 vaccine, now called Comirnaty
Read Time:45 Second

FDA approves Pfizer’s COVID-19 vaccine, now called Comirnaty

0 0

Enlarge / Empty Pfizer-BioNTech COVID-19 vaccine vials (credit: AHMAD GHARABLI)

The Food and Drug Administration has granted full approval of the Pfizer/BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty (koe-mir’-na-tee), the agency announced Monday.

The vaccine’s full approval—or Biologics License Application (BLA)—applies for use of a two-dose regimen, given three weeks apart, in people ages 16 years and older. It is the first BLA to be issued for a vaccine against COVID-19. The vaccine will still be available under an Emergency Use Authorization (EUA) for adolescents ages 12 to 15 and for use as a third booster dose in certain people with compromised immune systems.

The name Comirnaty—already in use elsewhere, including Europe—is a mash-up of “COVID-19 immunity” and “mRNA” that is meant to evoke the word “community.”

Read 7 remaining paragraphs | Comments

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Previous post This rare Nintendo Game & Watch just broke an auction record
Next post The US military may soon declassify a secret space weapon
Generated by Feedzy